SRS Acquiom applies one of the most extensive databases ever assembled on private M&A transactions. We innovate new services and publish studies that help you navigate the most complex post-closing issues.

About this Study

The 2012 SRS Life Sciences M&A Study analyzes 47 private-target acquisitions on which SRS served as the shareholder representative. Deals in this study closed from Q3 2008 through Q2 2012. Note that the sample sizes are larger for more recent years as a result of the growth of SRS.

Related Stories